Device, systems, kits and methods for rapid and simple detection of pathogens
OwnerNaama GEVA-ZATORSKY, Nadav BEN-ASSA +2inventors
InventorsNaama GEVA-ZATORSKY, Nadav BEN-ASSA, Rawi NADDAF, Tal GEFEN
Life of this patent
Estimating the term…
Abstract
The present disclosure provides devices, systems, kits and methods for rapid, simple self-sampling and self-performing detection of nucleic acid sequence of interest in a sample, specifically, nucleic acid sequences of pathogenic agents.
Claims21
1-40. (canceled)
Device for enabling detection of at least one nucleic acid sequence of interest in at least one sample, comprising a sample module and a reaction module, wherein:
- the sample module is configured for accommodating therein a plurality of sample preparation agents including at least a sample to be tested, and for enabling mixing of said plurality of sample preparation agents to provide a prepared sample, said sample module being configured for selectively allowing insertion of the sample into the sample module, and further configured for enabling delivery of said prepared sample to the reaction module;
- the reaction module comprises a plurality of reaction chambers, the device configured for selectively delivering a respective aliquot of said prepared sample to each said reaction chamber, wherein each said reaction chamber is configured for accommodating therein a respective quantity of a respective reaction mixture adapted for amplification reaction under isothermal conditions;
- the device is further configured for enabling reacting of each said respective aliquot of said prepared sample with each said respective reaction mixture in the respective said reaction chamber to produce at least one amplification product;
- and
- the device is further configured for enabling detecting a respective test parameter associated with said production of said at least one amplification product.
A method for the detection and monitoring of at last one nucleic acid sequence of interest in at least one sample, the method comprising the steps of:
- (a) contacting said sample or at least one aliquot thereof with an effective amount of at least one sample preparation agent to obtain at least one prepared sample;
- and
- (b) subjecting the at least one prepared sample of (a), or at least one aliquot thereof to at least one amplification reaction under isothermal conditions suitable for the production of at least one amplification product detectable by a detectable signal;
- wherein at least one of said amplification reaction/s is performed using at least one set of primers specific for at least one nucleic acid sequence of said nucleic acid sequence of interest;
- wherein the detection of a detectable signal indicates the presence of said nucleic acid sequence of interest in said sample, optionally, wherein said step (b) further comprises subjecting at least one aliquot of the prepared sample of (a) to at least one amplification reaction using at least one set of primers specific for at least one control nucleic acid sequence.
A kit comprising:
- (a) an effective amount of at least one protease, optionally comprised within a sample preparation module;
- (b) an amplification reaction mixture, optionally comprised within a reaction module that comprises a plurality of reaction chambers, each of said reaction chambers comprises said amplification mixture;
- wherein said reaction mixture is adapted for amplification reaction under isothermal conditions, and wherein said reaction mixture in at least one first said reaction chamber comprises at least one set of primers specific for at least one nucleic acid sequence of at least one pathogen;
- (c) at least one chaotropic agent comprised within at least one of the sample preparation module (a) and the reaction module (b), optionally,
- wherein said reaction mixture in at least one second said reaction chamber comprises at least one set of primers specific for at least one control nucleic acid sequence.
Dependencies are inferred from the claim text.